Highest-materiality recent filing
Crescent Capital BDC ups credit facility to $500M, issues $50M notes, repays $111.6M
Ninth Amendment increases borrowing facility from $400M to $500M; spread rises from 1.95% to 2.00%.
Crescent Capital BDC reports 2026 annual meeting voting results
Directors Susan Yun Lee and Michael S. Segal elected as Class II directors for three-year terms.
Net investment income of $15.5M ($0.42/share) vs $16.5M ($0.45) prior quarter; net loss of ($15.5M) or ($0.42)/share.
Director Ko resigns; CEO Breaux and President Chung elected to board
Elizabeth Ko resigned as director effective May 5, 2026; no disagreement with management or operations.
Crescent Capital BDC closes $135M senior notes issuance; swaps to floating rate
Issued $67.5M Tranche A notes at 5.87% due Feb 2029 and $67.5M Tranche B notes at 6.20% due Feb 2031.
Crescent BDC Q4 NII $0.45, full-year $1.81; NAV $19.10; Q1 dividend $0.42
Full-year net investment income $66.9M, or $1.81 per share, down from $2.40 in 2024.
Crescent Capital BDC Reports Q3 2025 Net Investment Income of $0.46 Per Share
Net investment income per share $0.46 for Q3 2025, down from $0.64 in Q3 2024.
Crescent Capital BDC issues $185M in senior unsecured notes across three tranches
Tranche A: $67.5M at 5.87%, due Feb 13, 2029; Tranche B: $67.5M at 6.20%, due Feb 13, 2031; Tranche C: $50M at 5.97%, due May 22, 2029.
Crescent Capital BDC reports Q2 2025 net investment income of $0.46 per share, NAV $19.55
Net investment income for Q2 2025 was $0.46 per share, including $0.02 of one-time accelerated amortization
Shareholders elect Briscoe and Strong as Class I directors; ratify E&Y auditor
Class I directors Kathleen S. Briscoe and George G. Strong, Jr. elected to three-year terms expiring at 2028 annual meeting.
Crescent BDC Q1 NII $0.45/sh; NAV down to $19.62; declares $0.42 base dividend
Net investment income of $0.45 per share; net income of $0.11 per share for Q1 2025.
Crescent Capital BDC amends credit facility: spread cut 50bps, size reduced to $400M
Eighth Amendment to Loan and Security Agreement with Wells Fargo executed April 10, 2025.
Crescent Capital BDC Q4 NII $0.55/shr; declares $0.42 base plus $0.15 special dividends
Q4 2024 net investment income $0.55/shr; net income $0.27/shr; NAV per share $19.98 (down from $20.20 prior qtr).
Crescent Capital BDC issues $115M senior notes at 6.77% and 6.90%
$35M 6.77% notes due Feb 18, 2028; $80M 6.90% notes due Feb 18, 2030.
Crescent Capital BDC amends credit facility, extends maturity to 2029, adds $25M term loan
Revolving commitment reduced from $350M to $285M; new $25M term commitment added; total facility $310M.
NII per share $0.64 (up from $0.59 Q3 2023); net income $0.41 vs $0.61 a year ago.
Crescent Capital BDC Q2 NII $0.59/sh, NAV $20.30; declares $0.42 base + $0.09 supplemental dividend
Net investment income per share $0.59 (up from $0.56 YoY); net income per share $0.55.
Crescent Capital BDC replaces analyst day replay with transcript after technical issues
Amendment dated June 17, 2024 corrects original June 11 8-K: replay unavailable due to technical issues.
Crescent Capital BDC holds Analyst & Investor Day on June 11, 2024; deck posted on website
Analyst & Investor Day held on June 11, 2024 via live video stream at 6:00 PM ET.
Reinvestment period extended to May 31, 2027; stated maturity to May 31, 2029.
Crescent Capital BDC stockholders elect Class III directors and ratify auditor
Elizabeth Ko elected as Class III director with 17,157,771 for, 193,647 withheld, 6,912,316 broker non-votes.
Crescent Capital BDC Q1 NII $0.63/share; NAV $20.28; raises quarterly dividend by $0.01
Net investment income of $0.63/share vs $0.54/share in Q1 2023; net income $0.76/share.
Crescent Capital BDC Q4 net investment income $0.61/sh; NAV $20.04; appoints Henry Chung President
Q4 net investment income $0.61/share ($22.8M) vs $0.52/share YoY; net income $0.83/share.
On and effective as of 12:00 a.m. midnight on May 5, 2026, the Board of Directors (the “Board”) of Crescent Capital BDC, Inc. (the “Company”) accepted the resignation of Elizabeth Ko as a member of the Board and a Class III Director.
On and effective as of 1:00 p.m. on May 7, 2026, the Board elected Mr. Jason Breaux as a Class III director, which is the class of directors that will stand for election at the Company’s 2027 Annual Meeting of Stockholders, or until a successor is duly elected and qualified.
On and effective as of 1:00 p.m. on May 7, 2026, the Board elected Mr. Henry Chung as a Class III director, which is the class of directors that will stand for election at the Company’s 2027 Annual Meeting of Stockholders, or until a successor is duly elected and qualified.
Mr. Chung succeeds Jason Breaux as the Company’s President. Mr. Breaux continues in his role as the Company’s Chief Executive Officer.
Effective February 15, 2024, the Board of Directors of the Company appointed Henry Chung, age 36, as its President.
Max materiality 0.70 · Median 0.55 · Most common event earnings